NCT02492815 PAN-EU Utilization, Effectiveness and Safety of Ipilimumab Administered in EAP Patients With Advanced Melanoma Status COMPLETED Phase N/A
NCT02488759 An Investigational Immuno-therapy Study to Investigate the Safety and Effectiveness of Nivolumab, and Nivolumab Combination Therapy in Virus-associated Tumors Status COMPLETED Phase PHASE1/PHASE2
NCT02488421 Real Evidence of Anticoagulation Treatment in Non-valvular Atrial Fibrillation in Germany, UK and France: REACT-AF2 Status COMPLETED Phase N/A
NCT02481830 Effectiveness Study of Nivolumab Compared to Chemotherapy in Patients With Relapsed Small-cell Lung Cancer Status COMPLETED Phase PHASE3
NCT02481297 Lirilumab With Rituximab for Relapsed, Refractory or High-risk Untreated Chronic Lymphocytic Leukemia (CLL) Patients Status COMPLETED Phase PHASE2
NCT02477826 An Investigational Immuno-therapy Trial of Nivolumab, or Nivolumab Plus Ipilimumab, or Nivolumab Plus Platinum-doublet Chemotherapy, Compared to Platinum Doublet Chemotherapy in Patients With Stage IV Non-Small Cell Lung Cancer (NSCLC) Status COMPLETED Phase PHASE3
NCT02475382 Expanded Access Program With Nivolumab Therapy for Treatment of Advanced/Metastatic SqNSCLC or Non-SqNSCLC After One Prior Systemic Regimen Status NO_LONGER_AVAILABLE Phase N/A
NCT02472977 Safety and Efficacy Study of Ulocuplumab and Nivolumab in Subjects With Solid Tumors Status TERMINATED Phase PHASE1/PHASE2
NCT02464969 Apixaban for the Acute Treatment of Venous Thromboembolism in Children Status COMPLETED Phase PHASE4
NCT02464657 Study of Idarubicin, Cytarabine, and Nivolumab in Patients With High-Risk Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML) Status COMPLETED Phase PHASE1/PHASE2
NCT02461602 Eliminate Thromboembolism: Improving Anticoagulation in Non-valvular Atrial Fibrillation Patients Status COMPLETED Phase N/A
NCT02460978 Dapagliflozin Evaluation in Patients With Inadequately Controlled Type 1 Diabetes Status COMPLETED Phase PHASE3
NCT02460068 A Study of Fotemustine(FTM) Vs FTM and Ipilimumab (IPI) or IPI and Nivolumab in Melanoma Brain Metastasis Status UNKNOWN Phase PHASE3
NCT02456844 Study to Investigate the Effect of BMS-986142 on the Pharmacokinetics (PK) of Methotrexate and Probe Substrate Cocktail in Healthy Patients Status COMPLETED Phase PHASE1
NCT02451982 Platform Study of Neoadjuvant and Adjuvant Immunotherapy for Patients With Resectable Adenocarcinoma of the Pancreas Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT02450682 Apixaban in Patients Who Undergo CIED Procedure- Randomized Pilot Study Status WITHDRAWN Phase PHASE2
NCT02447341 Profile and Antithrombotic Management of Patients With NVAF Attending Internal Medicine Departments in Spain (PERFILAR Study) Status COMPLETED Phase N/A
NCT02437279 Study to Identify the Optimal Adjuvant Combination Scheme of Ipilimumab and Nivolumab in Melanoma Patients Status UNKNOWN Phase PHASE1